about
Implementing the exercise guidelines for cancer survivorsPilot study of nitric oxide-donating aspirin in patients with pancreatic cancer painLongitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancerComplementary therapies for cancer-related symptoms.Attitudes toward vaccination for pandemic H1N1 and seasonal influenza in patients with hematologic malignancies.Neuromuscular complications of cancer diagnosis and treatment.Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis.Outpatient management of febrile neutropenia: concerns for the future.The refeeding syndrome in 2009: prevention is the key to treatment.The art of reinfusing intestinal secretions.Percutaneous vertebral augmentation: state of the art.Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach.Palliation of malignant dysphagia in esophageal cancer: a literature-based review.Endoscopic therapy for malignant bowel obstruction.Malignant bowel obstruction: comparing the treatments.Managing hematologic toxicities.TITAN: modifying an innovative American program for use with a European audience.Use of warfarin in the patient with cancer.Novel thrombopoietic agents: preliminary activity, potential benefit.A time for hope: promising advances in the management of anemia, neutropenia, thrombocytopenia, and mucositis.Implementation of cytokines to optimize cancer treatment outcomes.Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.What do perceived cognitive problems reflect?Cancer-related tasks involving employment: opportunities for clinical assistanceThe contribution of social factors to undereating in older adults with cancerPathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.The Development of an eHealth tool suite for prostate cancer patients and their partnersGender differences in the evolution of illness understanding among patients with advanced cancer.Costs and outcomes of acute kidney injury in critically ill patients with cancer.Management of thalidomide toxicity.Mechanisms and management of neuropathic pain in cancer.Oral mucositis in cancer therapy.Prevention and management of cardiotoxicity from antineoplastic therapy.A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial.Preventing and managing vesicant chemotherapy extravasations.Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial.The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).
P1433
Q27003664-B544CF82-585E-4B88-9806-8230D787ACE3Q28217382-E8CF16A8-2D7C-4118-8E70-46E8D86DD97CQ28298672-731AE9AC-AD08-47E5-9774-A249DB43CE15Q30344114-81852552-98EA-4A1F-8733-3D225E9E26DDQ30405550-1DD1806B-4E7E-427C-947C-A496F9A087C9Q30437730-1C108BD7-C3F9-4B73-B6F4-40D2E26D6489Q30443631-947A6ADB-882F-4529-89A2-B7E62E9FDAA2Q30446339-B6C75A44-9A5D-40F1-9D3F-FA2C3D06E071Q30448003-B6E32B0A-7C93-4CC3-A316-0C39D4838A3BQ30450834-E5BA2ECC-2219-49EC-9C73-45CF96A9E1F3Q30453214-756436A0-8913-49F2-BD09-DF8A709FE921Q31081596-91FD427B-D543-4947-93D5-E2732A698C47Q33258590-3CABC112-83FD-4432-B61B-F9712406B128Q33294614-071CE150-1B2E-4F6F-A513-9C04DF5284ACQ33294615-08BD61E9-A1BF-4AEE-A00A-B87B45B50DB5Q33362271-5EF6F116-8F59-42A3-B91A-341401E45F93Q33369598-EF536E78-ED3C-4210-9FF6-1B3ABFB2684CQ33374807-1562B209-7B50-4B61-945B-2F24C143A9ECQ33375487-791830AF-9FB4-4DC7-BDC3-D0A796ED833DQ33375488-F0A609E5-C90B-4877-9EF9-61647FEB58B6Q33375489-7407DB4A-0928-4E59-AF17-D8B78ABA3CBBQ33375851-F971FE62-D610-4BF6-B05F-38C932AA8835Q33442182-4F216EE6-C365-4C4C-BB2B-AC9A747C02ADQ33707551-2C14AD2B-58EE-47F2-AD92-465B22613009Q33791641-354E427E-E768-43CE-914B-89C4A4E0C48CQ33830960-1B948D4B-2ADB-4657-A7A5-CF85AA27271FQ33981179-EE29D882-ABDB-4453-8866-C3A8D20CCA1CQ33987349-016DE0B8-8E60-4DAD-AE6F-28855CA6E19BQ34039923-FDD49687-4EB2-41FE-9F7D-7716B679EDE2Q34070141-EB018E51-DCB2-4590-A0EB-315283B50C36Q34167427-0BFD5E23-7ED1-4741-8E3B-D84F1B9F56AFQ34205501-CF691B18-5F38-4EAE-88F1-B09D8649BEA9Q34343991-607B1767-2059-4FDA-B7CF-438418E0EB4CQ34346318-28B8CFB5-BE23-4778-A4B1-F13AAA1D4E67Q34377494-DF94B95C-FD3E-4A58-8477-EDD1952E5E02Q34550459-8197FB3A-2CDF-4329-9DAA-0560DD7DB758Q34555275-6A41199B-DDBD-440F-8378-CA6B1FC38F63Q34625235-2177AFEE-C1DD-45DC-AF4E-E05075905E9DQ34633236-FC7C8873-930F-45AD-A238-61AFC1AAF502Q34642390-320DF55B-8E5A-43B1-8F32-26D061745C46
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
The Journal of Supportive Oncology
@ast
The Journal of Supportive Oncology
@en
The Journal of Supportive Oncology
@es
The Journal of Supportive Oncology
@it
The Journal of Supportive Oncology
@nl
type
label
The Journal of Supportive Oncology
@ast
The Journal of Supportive Oncology
@en
The Journal of Supportive Oncology
@es
The Journal of Supportive Oncology
@it
The Journal of Supportive Oncology
@nl
prefLabel
The Journal of Supportive Oncology
@ast
The Journal of Supportive Oncology
@en
The Journal of Supportive Oncology
@es
The Journal of Supportive Oncology
@it
The Journal of Supportive Oncology
@nl
P3181
P1055
P1058
P1156
P1250
P1476
The Journal of Supportive Oncology
@en